Novavax, Inc. (NVAX)

6.80 -0.09 (-1.31%) USD  |  NASDAQ  |  Dec 23, 16:00
6.75 -0.05 (-0.74%) After-Hours: 05:35
More

Novavax SG&A Expense (TTM): 201.70M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.91B
Moderna, Inc. 1.061B
Merck & Co., Inc. 10.70B
Arcturus Therapeutics Holdings, Inc. 44.43M
Denali Therapeutics, Inc. 127.16M